Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
Pancreatic Ductal AdenoCarcinoma (PDAC) is one of the most lethal malignancies of all solid cancers. Precancerous lesions for PDAC include PanIN, IPMNs and MCNs. PDAC has a poor prognosis with a 5-year survival of approximately 6%. Whereas Periampulary AdenoCarcinoma (PAC) having four anatomic subty...
Gespeichert in:
Veröffentlicht in: | Current genomics 2018-09, Vol.19 (6), p.444-463 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Pancreatic Ductal AdenoCarcinoma (PDAC) is one of the most lethal malignancies of all
solid cancers. Precancerous lesions for PDAC include PanIN, IPMNs and MCNs. PDAC has a poor
prognosis with a 5-year survival of approximately 6%. Whereas Periampulary AdenoCarcinoma
(PAC) having four anatomic subtypes, pancreatic, Common Bile Duct (CBD), ampullary and duodenum
shows relative better prognosis. The highest incidence of PDAC has been reported with black
with respect to white population. Similarly, incidence rate of PAC also differs with different ethnic
populations. Several lifestyle, environmental and occupational exposures including long-term diabetes,
obesity, and smoking, have been linked to PDAC, however, for PAC the causal risk factors were
poorly described. It is now clear that PDAC and PAC are a multi-stage process resulting from the accumulation
of genomic alterations in the somatic DNA of normal cells as well as inherited mutations.
Approximately 10% of PDAC have a familial inheritance. Germline mutations in CDKN2A, BRCA2,
STK11, PALB2, PRSS1, etc., as well as certain syndromes have been well associated with predisposition
to PDAC. KRAS, CDKN2A, TP53 and SMAD4 are the 4 “mountains” (high-frequency driver
genes) which have been known to earliest somatic alterations for PDAC while relatively less frequent
in PAC. Our understanding of the molecular carcinogenesis has improved in the last few years due to
extensive research on PDAC which was not well explored in case of PAC. The genetic alterations that
have been identified in PDAC and different subgroups of PAC are important implications for the development
of genetic screening test, early diagnosis, and prognostic genetic markers. The present review
will provide a brief overview of the incidence and prevalence of PDAC and PAC, mainly, increased
risk in India, the several kinds of risk factors associated with the diseases as well as required
genetic alterations for disease initiation and progression. |
---|---|
ISSN: | 1389-2029 1875-5488 |
DOI: | 10.2174/1389202919666180221160753 |